SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-054347
Filing Date
2015-07-29
Accepted
2015-07-29 16:32:15
Documents
4
Period of Report
2015-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-16440_18k.htm 8-K 39948
2 EX-1.1 a15-16440_1ex1d1.htm EX-1.1 222368
3 EX-5.1 a15-16440_1ex5d1.htm EX-5.1 14576
4 GRAPHIC g164401kgi001.gif GRAPHIC 3467
  Complete submission text file 0001104659-15-054347.txt   283111
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 151013165
SIC: 3841 Surgical & Medical Instruments & Apparatus